Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
about
sameAs
Insight to drug delivery aspects for colorectal cancerThe wound healing, chronic fibrosis, and cancer progression triadHarnessing immunosurveillance: current developments and future directions in cancer immunotherapyThe therapeutic value of targeting inflammation in gastrointestinal cancersOxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal CancerImmunosuppression associated with chronic inflammation in the tumor microenvironmentPeroxisome proliferator-activated receptor δ promotes colonic inflammation and tumor growthMicrobiota regulation of inflammatory bowel disease and colorectal cancer.Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis.Chemokine-like factor 1-derived C-terminal peptides induce the proliferation of dermal microvascular endothelial cells in psoriasisCathelicidin, an antimicrobial peptide produced by macrophages, promotes colon cancer by activating the Wnt/β-catenin pathwayTh17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity.Cellular and molecular immunology of lung cancer: therapeutic implications.Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.Role of interleukin-6 in cachexia: therapeutic implications.Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.Association between two interleukin-2 gene polymorphisms and cancer susceptibility: a meta-analysis.Construction of interference vector targeting Ep-CAM gene and its effects on colorectal cancer cell proliferation.Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice.Expression of p38 mitogen-activated protein kinases, glycogen synthase kinase, c-Jun NH2-terminal kinase, extracellular signal-regulated kinase signaling: Can it be used as molecular markers among trauma-hemorrhagic shock patients?C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis.Chronic Inflammation in Skin MalignanciesAnti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis.Role of IL-17F T7488C polymorphism in carcinogenesis: a meta-analysis.Interleukin-17 facilitates the immune suppressor capacity of high-grade glioma-derived CD4 (+) CD25 (+) Foxp3 (+) T cells via releasing transforming growth factor beta.Advances and Prospects in Cancer ImmunotherapySaquinavir-NO Inhibits IL-6 Production in Macrophages
P2860
Q26774682-CDC0153E-D9B0-43D6-A048-CA2D0AAF8C02Q27014616-6917CE0E-D391-4C04-8F39-AA78BC563A05Q27021570-E33B4F03-C490-404E-A978-3A59913134A6Q27024203-F28438D8-548B-4CE6-911B-FFD422DF3859Q28073745-987C9865-ABFF-44B2-AADE-728B3822040FQ28083450-21990ED4-1DAE-4962-89E4-6524C91A837EQ33627388-FE0AB26C-6890-476E-BFB2-38146784B3FEQ35000300-52367492-FA36-4692-A166-0F24A2C86230Q35070335-B7188A5D-A53D-41F8-BF0F-18FBD2A1F13DQ35542124-65A811B7-95F7-4685-875D-A3EFB8D36B11Q35550144-5F09B554-2312-45D8-9DD5-6C1E5C5563C2Q35824820-3CA7D65E-CFE8-4F91-A689-E85F7213F35BQ36060253-AFEA3674-F3E2-470A-A9DB-FDA7042F8AC9Q36130505-971306A0-C948-4249-B278-F2BBEB4E07F4Q37697529-157261DF-DF18-4D9C-BE18-4C37D58DE2ABQ38260561-1334FE9C-AC65-43E9-9955-86131C0C8E6EQ38829160-3DF608A8-C09C-45DB-8D9C-D47EDC2B65B5Q39022042-8AB82A81-22DF-4882-927E-E137DDC4113DQ39045958-B518BC24-603C-4E79-8B7B-7A0B74F1FE8BQ40655925-A0B19224-686A-4479-BDFE-CE25E184D611Q40954412-501F6FE9-AAE3-42EE-8CC5-DE63D27EB8BAQ41143701-0F04D076-36A6-4602-959C-0A856D1CE923Q41612495-321EFE3B-9A9F-4D42-9C8F-A873D6815F66Q41891599-C42707F4-5F5C-4877-9E16-C468D74C4A9FQ42635450-6661D6B7-8C69-4FA9-A1FA-4F8862B2EB2FQ46489977-0E911B73-7391-4813-9934-BB2CFFE6D863Q47160621-20975731-4A17-4241-885B-C50042973DE3Q53236140-1018E1B0-ABFB-482F-AB4D-43C9D1851D0EQ55460935-D393D5CE-7272-42D8-BDAD-918E218596D0Q59072375-EBBF7AFC-F10C-4868-8124-7BE45E559C78Q59089968-29C2F733-6FC7-4FBA-A868-DB202D502586
P2860
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@ast
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@en
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@nl
type
label
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@ast
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@en
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@nl
prefLabel
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@ast
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@en
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@nl
P3181
P1476
Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
@en
P2093
Kepeng Wang
Sergei I Grivennikov
P304
P3181
P356
10.1136/ANNRHEUMDIS-2012-202201
P407
P433
P577
2012-12-19T00:00:00Z
2013-04-01T00:00:00Z